Abstract
During the period 1987 to 1991 a retrospective study was performed to determine the resistance of thermotolerant Campylobacter species isolated from feces to erythromycin and fluoroquinolones. Of the 672 strains studied, 614 (91.3%) were identified as Campylobacter jejuni and 58 (8.7%) as Campylobacter coli. During the study period the rate of resistance of Campylobacter jejuni to erythromycin remained relatively stable (0.9-3.5%), while resistance of Campylobacter coli to erythromycin emerged later (1989) with much higher rates (14.8-33%). Overall, 11.8% and 10.7% of Campylobacter jejuni strains isolated after 1987 were resistant to nalidixic acid and ciprofloxacin respectively, resistance increasing from 2.3% in 1988 to 32% in 1991. In 1991 the first strains of Campylobacter coli with resistance to these fluoroquinolones were detected (rates 29% and 26% respectively). Of the strains resistant to nalidixic acid, only 10.9% were susceptible to ciprofloxacin.
MeSH Terms
Anti-Infective Agents/therapeutic use
Campylobacter/drug effects
Campylobacter Infections/drug therapy
Campylobacter coli/drug effects,isolation & purification
Campylobacter jejuni/drug effects,isolation & purification
Child
Drug Resistance, Microbial
Erythromycin/therapeutic use
Feces/microbiology
Fluoroquinolones
Hot Temperature
Humans
Retrospective Studies
Chemicals
Anti-Infective Agents
Fluoroquinolones
Erythromycin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Reina J
Clinical Microbiology Service, Hospital Son Dureta, Palma de Mallorca, Spain.
Borrell N
Serra A
References (14)
14 references, click to expand
-
Erythromycin-resistant Campylobacter infections in Thailand.
Antimicrob Agents Chemother. 1987 Mar;31(3):438-42
PMID: 3579261
-
A demographic survey of campylobacter, salmonella and shigella infections in England. A Public Health Laboratory Service Survey.
Epidemiol Infect. 1987 Dec;99(3):647-57
PMID: 3428371
-
Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products.
Lancet. 1990 Mar 31;335(8692):787
PMID: 1969524
-
Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.
J Antimicrob Chemother. 1991 Feb;27(2):199-208
PMID: 2055811
-
[Isolation of nalidixic acid resistant Campylobacter jejuni].
Enferm Infecc Microbiol Clin. 1989 May;7(5):288-9
PMID: 2490735
-
Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.
J Clin Microbiol. 1987 Sep;25(9):1807-8
PMID: 3654954
-
Treatment of Campylobacter-associated enteritis with erythromycin.
Am J Dis Child. 1983 Mar;137(3):282-5
PMID: 6337473
-
Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada.
Can J Microbiol. 1986 Jan;32(1):28-32
PMID: 3008970
-
Fluoroquinolone-resistance in thermophilic Campylobacter spp isolated from stools of Spanish patients.
Lancet. 1990 Jul 21;336(8708):186
PMID: 1973508
-
Erythromycin-resistant campylobacters.
Lancet. 1978 Dec 23-30;2(8104-5):1385
PMID: 82888
-
The genus Campylobacter: a decade of progress.
Clin Microbiol Rev. 1988 Apr;1(2):157-72
PMID: 3069194
-
Potential role of fluoroquinolones in pediatric infections.
Rev Infect Dis. 1989 Nov-Dec;11(6):878-89
PMID: 2513628
-
Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.
Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):953-7
PMID: 1794366
-
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.
Antimicrob Agents Chemother. 1991 Oct;35(10):2065-9
PMID: 1759828